Bruce Artim

Registered Lobbyist
Disclosed Prior Positions
Senate Judiciary Committee Staff Member 1995-2006; (Chief Counsel and Staff Director 2003-04); Intellectual Property Subcommittee - Chief Counsel and Staff Director 2005-06)
HHS detailee to U.S. Senate Judiciary Committee (1995-2006)(Staff Director/Chief Counsel 2003- 2004) HHS/PHS/NIH Employee 1986 - 1995
Lobby Filings
22
Clients
1
Firms
1
Years Active
2018–2023
Total Contributed
$11,800
Contributions
16
Recipients
8
Contrib Filings
15
Top Recipient Legislators
LegislatorPtyStTotal
Ron Wyden D OR $5,800
Mazie Hirono D HI $3,000
Thomas Tillis R NC $1,000
Doug Collins R GA $500
Brett Guthrie R KY $500
Kevin Kiley R CA $250
Christopher Coons D DE $250
Top Committees / PACs
PayeeCountTotal
ACT BLUE RON WYDEN 2 $5,800
ACTBLUE/MAZZIE FOR HIRONO 3 $1,500
ACT BLUE 2 $1,000
ACTBLUE 3 $750
THOMPAC 1 $500
GUTHRIE FOR CONGRESS 1 $500
COLLINS FOR SENATE 1 $500
WIN RED 1 $500
FRIENDS OF AMANDA MAKKI 1 $500
KEVIN KILEY FOR CONGRESS 1 $250

Lobbying Filings

All 2023 2022 2021 2020 2019 2018
YearFirmClientIncomeDoc
2023
4th Quarter - Termination		 REGENXBIO REGENXBIO —
2023
3rd Quarter - Report		 REGENXBIO REGENXBIO —
2023
2nd Quarter - Report		 REGENXBIO REGENXBIO —
2023
1st Quarter - Report		 REGENXBIO REGENXBIO —
2022
4th Quarter - Report		 REGENXBIO REGENXBIO —
2022
3rd Quarter - Report		 REGENXBIO REGENXBIO —
2022
2nd Quarter - Report		 REGENXBIO REGENXBIO —
2022
1st Quarter - Report		 REGENXBIO REGENXBIO —
2021
4th Quarter - Report		 REGENXBIO REGENXBIO —
2021
AMENDED		 REGENXBIO REGENXBIO —
Page 1 of 3  ·  22 filings Next

Political Contributions

All 20232022202120202019
Recipient / Honoree Legislator Payee / Committee Date Amount
Sen. Thom Tillis Thomas Tillis (R, NC) WIN RED Nov 2, 2020 $500
Sen. Mazie Hirono Mazie Hirono (D, HI) ACT BLUE Nov 2, 2020 $500
Rep. Doug Collins Doug Collins (R, GA) COLLINS FOR SENATE Nov 2, 2020 $500

Contribution Filings (LD-203)

YearPeriodPostedStatusDoc
2023 Year End Jan 19, 2024 Active
2023 Year End Nov 7, 2023 Active
2023 Mid Year Jul 19, 2023 Active
2022 Year End Jan 18, 2023 Active
2022 Year End Jan 18, 2023 Active
2022 Year End Oct 31, 2022 Active
2022 Mid Year Oct 31, 2022 Active
2021 Year End Jun 14, 2022 Active
2021 Mid Year Sep 29, 2021 Active
2021 Mid Year Sep 15, 2021 Active
2020 Year End Jan 31, 2021 Active
2020 Mid Year Jul 20, 2020 None
2019 Year End Jan 31, 2020 Active
2019 Mid Year Jul 31, 2019 None
2018 Year End Mar 25, 2019 None